Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Akero : Phase 2a BALANCED Study Shows Potential Of Efruxifermin As Foundational NASH Monotherapy


RTTNews | Nov 13, 2020 08:08AM EST

08:07 Friday, November 13, 2020 (RTTNews) - Akero : Phase 2a BALANCED Study Shows Potential Of Efruxifermin As Foundational NASH Monotherapy

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC